FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

2 Charged in Insys Fentanyl Kickback Scheme

Two Florida men are charged as part of an Insys Subsys kickback and bribery scheme.

Human Drugs

Supplement Market Not Perfectly Regulated: Tave

FDA dietary supplements director Steven Tave tells an industry conference about a regulatory gap between what the law requires and what enforcement ca...

Human Drugs

FDA Priority Review for Niemann-Pick Disease Drug

FDA accepts for priority review a CytRx NDA for arimoclomol for treating Niemann-Pick disease Type C.

Human Drugs

Trumps Dangerous Meddling at FDA and CDC

A Washington Post opinion piece takes issue with President Trump and his administrations meddling for political purposes in FDA and CDC activities rel...

Human Drugs

Use Drug Master File for Cannabis Proprietary Info: FDA

FDA encourages stakeholders who are developing drugs containing cannabis to consider using the drug master file pathway to protect proprietary informa...

Federal Register

AstraZeneca Wins Priority Voucher for Koselugo

Federal Register notice: FDA issues a priority review voucher to AstraZeneca for an approved rare pediatric disease product Koselugo (selumetinib).

Federal Register

Draft Guide on Geriatric Information in Drug Labels

Federal Register notice: FDA makes available a draft guidance entitled Geriatric Information in Human Prescription Drug and Biological Product Labelin...

Human Drugs

California Could Partner in Drug Manufacturing: Report

Attorney Sara Koblitz says Californias governor is considering signing legislation that would make the state a partner in drug manufacturing and distr...

Federal Register

Guidance on Eosinophilic Esophagitis Drug Development

Federal Register notice: FDA makes available a final guidance entitled Eosinophilic Esophagitis: Developing Drugs for Treatment.

Human Drugs

FDA Misinterpreted Law in Goprelto Case, Court Says

The DC federal court says FDA misinterpreted the FFDCA when it approved Lannetts Numbrino during the new chemical entity exclusivity period for Genus ...